MC
CBPO

Martin Currie’s China Biologic Products Holdings, Inc. CBPO Stock Holding History

Martin Currie’s Portfolio CBPO Stock Details CBPO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q3 		– Sell
-1,700
Closed -$192K – 109
2017
Q2 		$192K Buy
1,700
+100
+6% +$11.2K 0.02% 101
2017
Q1 		$160K Sell
1,600
-400
-20% -$42.7K 0.01% 103
2016
Q4 		$215K Sell
2,000
-100
-5% -$11.7K 0.02% 103
2016
Q3 		$261K Sell
2,100
-100
-5% -$11.8K 0.02% 100
2016
Q2 		$234K Buy
2,200
+600
+38% +$69.7K 0.02% 94
2016
Q1 		$183K Sell
1,600
-1,100
-41% -$129K 0.02% 92
2015
Q4 		$385K Sell
2,700
-700
-21% -$80.8K 0.04% 84
2015
Q3 		$305K Sell
3,400
-400
-11% -$42.2K 0.03% 83
2015
Q2 		$438K Buy
3,800
+1,300
+52% +$137K 0.04% 81
2015
Q1 		$239K Buy
+2,500
New +$187K 0.02% 89

Other funds holding CBPO

Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Schroder Investment Management Group
Schroder Investment Management Group London, United Kingdom $122B AUM 29.27% 1-Year Est. Return
Fidelity International
Fidelity International Hamilton, Bermuda $129B AUM 30.83% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
HIM
Hermes Investment Management London Uk, United Kingdom $7.52B AUM 20.67% 1-Year Est. Return

Martin Currie's CBPO Position: Q3 2017 in Review

Martin Currie sold out of China Biologic Products Holdings, Inc. (CBPO) in Q3 2017, closing a stake of 1,700 shares — an estimated $192K sold.

Martin Currie first reported a position in CBPO in Q1 2015 and held it in 10 quarters. The position peaked at $438K in Q2 2015. 94 funds tracked by Wall St. Rank hold CBPO as of Q3 2017.

  • Martin Currie reported no remaining China Biologic Products Holdings, Inc. position as of Q3 2017 after selling out during the quarter.
  • Martin Currie sold 1,700 China Biologic Products Holdings, Inc. shares in Q3 2017, an estimated $192K.
  • Martin Currie first reported a position in China Biologic Products Holdings, Inc. in Q1 2015 and held it in 10 quarters.
  • Martin Currie's China Biologic Products Holdings, Inc. position peaked at $438K in Q2 2015.
  • 94 funds tracked by Wall St. Rank held China Biologic Products Holdings, Inc. as of Q3 2017.

Based on Martin Currie's 13F filing for Q3 2017, filed 14 Nov 2017.